We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$809M
AUM Growth
+$404M
Cap. Flow
+$238M
Cap. Flow %
29.41%
Top 10 Hldgs %
38.43%
Holding
159
New
60
Increased
32
Reduced
34
Closed
31

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$27.3M
2
ABBV icon
AbbVie
ABBV
+$22.4M
3
ISRL
Isramco Inc
ISRL
+$22.2M
4
SHPG
Shire pic
SHPG
+$19.6M
5
PFE icon
Pfizer
PFE
+$18.3M

Sector Composition

Rank Sector Weight
1 Healthcare 59.53%
2 Miscellaneous 26.6%
3 Technology 4.45%
4 Energy 3.1%
5 Industrials 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TISA
151
DELISTED
TOP Image Systems Ltd
TISA
-20,000
Closed -$79K
CORI
152
DELISTED
Corium International, Inc.
CORI
-69,100
Closed -$537K
IPXL
153
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
-1,000
Closed -$550K
LMNS
154
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
-245
Closed
AUXL
155
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
-935
Closed -$40K
AMBI
156
DELISTED
Ambit Biosciences Corp
AMBI
-277,568
Closed -$1.92M
CYTR
157
DELISTED
CytRx Corp
CYTR
-66,667
Closed -$1.67M

Similar funds

Sphera Funds Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sphera Funds Management held 159 positions worth $809M, up 99% from $406M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sphera Funds Management deployed $238M of net new capital in Q3 2014, opening 60 new positions and adding to 32 existing holdings. Its largest new stake was Allergan plc: 122,100 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 76% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was GSK, an estimated $9.95M trimmed.

  • Sphera Funds Management's largest Q3 2014 buy was Allergan plc: 122,100 shares worth $29.5M.
  • Sphera Funds Management added most to Shire pic in Q3 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q3 2014 reduction was GSK, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Sanofi in Q3 2014, selling an estimated $12.7M.
  • Sphera Funds Management's ten largest holdings make up 38% of its $809M portfolio in Q3 2014.
  • Sphera Funds Management opened 60 new positions and closed 31 in Q3 2014.
  • Sphera Funds Management's portfolio value rose 99% quarter-over-quarter to $809M.

Based on Sphera Funds Management's 13F filing for Q3 2014, filed 13 Nov 2014.